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Previous studies have established an important role of histone acetylation in transcriptional control by
nuclear hormone receptors. With chromatin immunoprecipitation assays, we have now investigated whether
histone methylation and phosphorylation are also involved in transcriptional regulation by thyroid hormone
receptor (TR). We found that repression by unliganded TR is associated with a substantial increase in
methylation of H3 lysine 9 (H3-K9) and a decrease in methylation of H3 lysine 4 (H3-K4), methylation of H3
arginine 17 (H3-R17), and a dual modification of phosphorylation of H3 serine 10 and acetylation of lysine 14
(pS10/acK14). On the other hand, transcriptional activation by liganded TR is coupled with a substantial
decrease in both H3-K4 and H3-K9 methylation and a robust increase in H3-R17 methylation and the dual
modification of pS10/acK14. Trichostatin A treatment results in not only histone hyperacetylation but also an
increase in methylation of H3-K4, increase in dual modification of pS10/acK14, and reduction in methylation
of H3-K9, revealing an extensive interplay between histone acetylation, methylation, and phosphorylation. In
an effort to understand the underlying mechanism for an increase in H3-K9 methylation during repression by
unliganded TR, we demonstrated that TR interacts in vitro with an H3-K9-specific histone methyltransferase
(HMT), SUV39H1. Functional analysis indicates that SUV39H1 can facilitate repression by unliganded TR and
in so doing requires its HMT activity. Together, our data uncover a novel role of H3-K9 methylation in
repression by unliganded TR and provide strong evidence for the involvement of multiple distinct histone
covalent modifications (acetylation, methylation, and phosphorylation) in transcriptional control by nuclear
hormone receptors.
In eukaryotic cells, genomic DNA is complexed with histone
and nonhistone proteins to form chromatin. The N-terminal
tails of histone proteins are known to undergo a number of
posttranslational covalent modifications, including acetylation,
methylation, phosphorylation, ubiquitination, and ADP-ribo-
sylation (55). Such posttranslational modifications have long
been thought to play important roles in chromatin structure
and function (50, 54). The identification and characterization
of a large number of histone acetyltransferases and histone
deacetylases (HDACs) over the last several years have firmly
established the functional importance of histone acetylation in
chromatin structure and function (13, 40, 46, 60). First re-
ported in 1964, histones have long been known to undergo
methylation (33). Early studies have identified methylation in
multiple lysine residues, including lysines 4, 9, 27, and 36 of H3
and lysine 20 in H4. In addition, histones can be methylated on
arginine residues. The identification and characterization of
several histone methyltransferases (HMTs) (8, 36, 39, 44, 47,
52, 53) have provided new insights into the role of histone
methylation in chromatin function and gene transcription.
Human (SUV39H1) and fission yeast (Clr4) homologs of
Drosophila Su(var)3-9 have recently been shown to encode
HMTs that selectively methylate histone H3 at K9 (39). The
HMT activity of these proteins is conferred through their
highly conserved SET domain (39), and recently, this modifi-
cation has been shown to generate a binding site for hetero-
chromatin protein 1 (HP1) (2, 22), providing a strong link
between H3-K9 methylation, gene silencing, and heterochro-
matin formation. H3-K9 methylation also inhibits the phos-
phorylation of serine 10 in H3, a modification that has been
shown to be involved in gene activation and chromosome con-
densation/segregation (11, 28, 29). Importantly, H3-K9 meth-
ylation has also been found to occur outside of heterochroma-
tin, as recent studies showed that the retinoblastoma protein
interacts with and targets SUV39H1 for methylation and re-
pression of the cyclin E promoter (35, 49). Besides SUV39
family proteins, one additional HMT, G9a, has been reported
to methylate K9 as well as K27 of H3 (47).
HMTs that specifically methylate H3-K4 have also been
identified recently (6, 36, 52). One H3-K4 HMT, Set9, has
been shown to potentiate transcription activation through its
ability to methylate H3-K4. Methylation of H3-K4 antagonizes
methylation in H3-K9, facilitates acetylation by p300, and pre-
cludes binding of the NURD complex to H3 N-terminal tails,
supporting a role for H3-K4 methylation in transcription acti-
vation (36, 52). However, work with Saccharomyces cerevisiae
indicates that H3-K4 methylation may be involved in transcrip-
tion repression (6). In S. cerevisiae, Set1 is likely to be the
major if not the only enzyme responsible for H3-K4 methyl-
ation. Genetic experiments indicate that Set1 is required for
ribosomal DNA (rDNA) silencing and silencing at telomeres
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and mating type loci (HML) (6). Thus, the effect of H3-K4
methylation on transcription seems to be context dependent.
Outside of lysine methylation of histones, two arginine-spe-
cific HMTs, PRMT1 and CARM1, have been reported to
function as coactivators for nuclear hormone receptors (NR)
(3, 8, 30, 47, 53). PRMT1 methylates H4 arginine 3 (H4-R3)
(53), and CARM1 methylates H3 arginine 17 (H3-R17) as well
as arginines 3 and 26 (41). Notably, methylation of H4-R3
facilitates subsequent acetylation by p300, providing a molec-
ular explanation for the observed coactivator activity of
PRMT1. Collectively, such diversity in histone N-terminal tail
modifications and their reported effects in combination has led
to the proposal of a “histone code” hypothesis, which is defined
by the ability of distinct or similar histone modifications to act
in combination to bring about distinct biological events (19,
43).
Nuclear hormone receptors are a large group of structurally
related transcription factors whose transcriptional activities are
generally regulated by lipophilic ligands (31). As members of
the NR superfamily, the thyroid hormone receptor (TR) and
retinoic acid receptor (RAR) have the capacity to alternately
repress and activate transcription depending on the absence or
presence of their cognate ligands (12, 18, 32, 38, 48). Studies
over the last several years indicate that TR and RAR make use
of distinct cofactors and chromatin modification to accomplish
their dual functions in transcription (48, 56). While activation
by liganded receptors is associated with the recruitment of
coactivators and targeted acetylation of chromatin (9, 42), re-
pression by unliganded receptors is mediated through interac-
tion with the corepressors SMRT and N-CoR and recruitment
of HDAC activities (10, 14, 16, 24, 25). Although HMTs such
as PRMT1 and CARM1 have been shown to facilitate tran-
scriptional activation by NRs (3, 8, 53), it has not yet been
reported whether histone methylation on lysines is also in-
volved in transcriptional control by NRs.
In this study, we investigated the involvement of multiple
histone modifications in transcription regulation by TR with
chromatin immunoprecipitation (ChIP) assays. We demon-
strate that transcriptional regulation by TR involves, in addi-
tion to the expected changes in acetylation, methylation of
H3-K4, H3-K9, and H3-R17 and phosphorylation of H3-S10.
Among these modifications, H3-K9 methylation increases sig-
nificantly during repression by unliganded TR and is reduced
during activation by liganded TR. We show that TR interacts
with an H3-K9-specific HMT, SUV39H1, and that SUV39H1
facilitates repression by unliganded TR in an HMT activity-
dependent manner. Together, our data uncover a novel role of
H3-K9 methylation in repression by unliganded TR and pro-
vide strong evidence for the involvement of multiple distinct
types of histone covalent modifications (acetylation, methyl-
ation, and phosphorylation) in transcriptional control by nu-
clear receptors.
MATERIALS AND METHODS
Plasmid constructs. The 4xUAS.TRA reporter was described previously
(24). The 4xUAS.TK-CAT reporter was kindly provided by Katia Georgopoulos
(Harvard Medical School). The preparation of single-stranded DNA of reporters
was done as described previously (59). The construct for in vitro synthesis of
mRNA encoding GAL4-TR (GAL4 DNA-binding domain [DBD], amino acids
1 to 147) fused to the ligand-binding domain of Xenopus TRA (amino acids 86
to 369) has been described (24). To generate a construct for in vitro synthesis of
mRNA encoding human HMT SUV39H1, the full-length SUV39H1 was in-
serted in frame into a modified pSP64(polyA) (Promega) vector containing an
N-terminal Flag tag (F-SUV39H1). The HMT-defective mutant SUV39H1m
(H324K) was generated by PCR-based mutagenesis, and the mutation was ver-
ified by DNA sequencing.
Microinjection of Xenopus oocytes and subsequent analyses of protein expres-
sion, chromatin structure, and transcription. Preparation and microinjection of
mRNAs and reporter DNA into stage VI Xenopus oocytes were done as de-
scribed previously (59). All mRNAs for microinjection were synthesized in vitro
with SP6 mMessage mMachine kits from Ambion. Unless indicated in the figure
legends, mRNA was injected at a concentration of 100 ng/l (18.4 nl/oocyte), and
single-stranded reporter DNA at a concentration of 50 ng/l (18.4 nl/oocyte)
according to the experimental scheme indicated in each figure. The injected
oocytes were incubated at 18°C overnight and processed for transcriptional
analysis by primer extension and assayed for chromatin structure by partial
micrococcal nuclease digestion as described previously (59). The internal control
for transcription is the primer extension product of the Xenopus storage histone
H4 mRNA (58). Western blotting analyses for expression of F-SUV39H1 and
F-SUV39H1m were carried out with a Flag tag-specific antibody (M2) purchased
from Sigma, whereas Western analysis of GAL4-TR expression was performed
with a GAL4 DBD-specific antibody purchased from Santa Cruz Biotechnology
(sc-510).
ChIP assays. The ChIP assays for histone methylation and acetylation were
performed essentially as described previously (24). In brief, after overnight
incubation, the groups of injected oocytes were treated with 1% formaldehyde
for 10 min. The oocytes were washed twice with phosphate-buffered saline (PBS)
solution and incubated with 100 mM Tris (pH 9.4)–10 mM dithiothreitol (DTT)
at 30°C for 15 min. The oocytes were then rinsed once and resuspended in
homogenization buffer (50 l/oocyte) (20 mM Tris [pH 7.6], 60 mM KCl, and 1
mM DTT) and homogenized by pipetting. The homogenates were sonicated in a
cold room to break chromatin into average 300- to 500-bp fragments. After
centrifugation with a benchtop microcentrifuge (15 min at 13,000 rpm) to remove
insoluble materials, the extracts were diluted onefold with ChIP I buffer (0.1%
sodium deoxycholate, 1% Triton X-100, 2 mM EDTA, 50 mM HEPES [pH 7.6],
150 mM NaCl, 1 mM DTT, and 0.4 mM phenylmethylsulfonyl fluoride [PMSF])
and used for ChIP assays (each reaction with 100 l of extract and 1 l of
individual antibody) as described previously (42).
The antibodies against acetylated H3 and H4, methylated H4-R3 and H3-R17,
and H3-S10/acK14 were purchased from Upstate Biotechnology. The antibodies
against methylated H3-K4 and H3-K9 were described previously (6, 39). The
PCR A reaction (5 primer, TGCCAGGGCCTATTTTGAATC, and 3 primer,
AGAGCCTGAGTGAAGCCCATAAG) generated a 100-bp PCR product,
whereas the PCR B reaction (5 primer, CAGTGCTGCAATGATACCGCGA
GA, and 3 primer, GAGGCGGATAAAGTTGCAGGACCA) generated a
115-bp fragment. The final PCRs were carried out with inclusion of 1 Ci of
[32P]dCTP in each PCR, and the PCR product was visualized by autoradiography
after fractionation on a 6% native polyacrylamide gel. The quantification of ChIP
results was carried out with a PhosphorImager and by setting the value in control
samples to 1.
HMT activity assays. The HMT activity assays with calf thymus core histones
as substrates were performed primarily as described previously (45). Briefly,
when HeLa or Xenopus oocyte extracts were used, 5 g of HeLa or Xenopus
oocyte extract was incubated in 25 l of reaction mix with 2.5 g of calf thymus
core histones (Roche Molecular Biochemicals) along with 0.5 Ci of S-adenosyl-
L-[methyl-3H]methionine ([3H]SAM) in HMT buffer (50 mM Tris [pH 8.0], 1
mM PMSF, and 0.5 mM DTT) at 30°C for 1 h. The core histones were fraction-
ated by sodium dodecyl sulfate–15% polyacrylamide gel electrophoresis (SDS–
15% PAGE) followed by Coomassie staining and fluorography.
To assay for HMT activity in corepressor complexes of Sin3, Mi-2/NURD,
SMRT, and N-CoR, the corresponding complexes were immunoprecipitated
from 500 g of HeLa nuclear extracts by incubating in 200 l of immunopre-
cipitation buffer (25 mM Tris [pH 8.0], 150 mM NaCl, 1 mM DTT, 0.1% NP-40,
and 1 mM PMSF) with antibodies (5 l) specific for Sin3A (AK-11; Santa Cruz
Biotechnology), CHD4 (kindly provided by Weidong Wang, National Institute
on Aging), SMRT (raised against SMRT amino acids 1165 to 1363), and N-CoR
(raised against N-CoR amino acids 1 to 373) (25), respectively. After 1 h of
incubation in a cold room with rotation, 10 l of 50% protein A-Sepharose beads
was added to each tube and further incubated for 2 h. The beads were then
collected by centrifugation and washed five times with the immunoprecipitation
buffer and a final wash with HMT buffer. The beads from each immunoprecipi-
tation were divided into two halves; one was used for the HMT activity assay as
described above and the other was used for the HDAC activity assay as described
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previously (25). In the experiment shown in Fig. 4B, the HMT assays were
carried out as described previously except that unlabeled SAM substrate (100
M final concentration) was used. H3-K9 methylation was subsequently detected
by Western blotting analysis with the antibody against H3-K9.
RESULTS
Methylation of H3-K9 increased during repression by unli-
ganded TR and decreased during activation by liganded TR.
We have shown previously that expression of TR and its het-
erodimer partner retinoid X receptor in Xenopus oocytes re-
presses transcription in the absence of T3 and activates tran-
scription in the presence of T3 from a Xenopus TRA
promoter-based reporter assembled into chromatin via a rep-
lication-coupled pathway (57, 59). We have demonstrated
more recently by chromatin immunoprecipitation (ChIP) as-
says that repression by unliganded TR/retinoid X receptor or a
fusion of the GAL4 DBD (1 to 147) and TR ligand-binding
domain (83 to 309) (referred to as GAL4-TR hereafter) is
correlated with the recruitment of corepressor SMRT and
N-CoR complexes and deacetylation of histones over the pro-
moter region (24).
Given the recent evidence for functional significance of his-
tone methylation in transcriptional control and the proposed
histone code hypothesis (19, 43), we sought to investigate the
involvement of histone methylation in transcriptional regula-
tion by TR. Considering the potential role of H3-K9 methyl-
ation in transcriptional repression, we first tested whether re-
pression by unliganded TR could also utilize K9 methylation in
H3. To this end, we used an experimental scheme (Fig. 1A) to
express GAL4-TR in Xenopus oocytes by injection of its
mRNA synthesized in vitro into the cytoplasm. We then as-
sembled a modified pTRA reporter containing four copies of
the GAL4 binding site (4xUAS.TRA) into chromatin via a
replication-coupled chromatin assembly pathway by injection
of its single-stranded DNA into the nuclei of oocytes (1). The
injected DNA was shown to assemble into chromatin by partial
micrococcal nuclease digestion followed by Southern hybrid-
ization (Fig. 1B). As expected, primer extension analysis re-
vealed that GAL4-TR repressed transcription in the absence
of T3 and activated transcription in the presence of T3 from
the injected reporter (Fig. 1D). The internal control represents
the primer extension product from the endogenous storage
histone H4 mRNA and served as a loading control.
We next used ChIP assays to determine whether the level of
H3-K9 methylation changed under different conditions with an
antibody specific for H3 methylated at K9 (anti-mH3-K9). This
antibody has been well demonstrated to be specific for K9-
methylated H3 in both Western blotting analysis and ChIP
assays (22, 27, 37, 39). In parallel, we also analyzed the level of
H3 acetylation by ChIP assays with an acetylated-H3-specific
antibody. While control ChIP assays (protein A-Sepharose
beads only) gave virtually no background, a low level of signal
was detected over both the promoter vicinity (PCR A) and a
distal region about 2 kb downstream of the transcriptional start
site (PCR B) with the anti-mH3-K9 antibody (Fig. 1E). This
result indicates that some H3 proteins in our chromatin tem-
plates were methylated at K9. Notably, the level of K9 meth-
ylation increased significantly (4.8-fold) in the promoter vicin-
ity region (PCR A, compare lanes 8 and 7) when transcription
was repressed by unliganded TR. In contrast, the level of K9
methylation decreased during activation by liganded TR (PCR
A, compare lanes 9 and 7).
Since no significant difference in K9 methylation was ob-
served at the distal region (PCR B), the increased K9 methyl-
ation during repression by unliganded TR appears to be a
localized event targeted to the promoter vicinity. ChIP assays
FIG. 1. Changes in H3-K9 methylation during repression and acti-
vation by unliganded and liganded TR. (A) Diagram showing the
experimental scheme. (B) Diagram illustrating the structure of the
4xUAS.TRA reporter. (C) Partial micrococcal nuclease digestion
(MNase) assay demonstrated the assembly of injected DNA into chro-
matin. Two hours after DNA injection, oocytes were homogenized and
aliquoted into three tubes. Chromatin was then partially digested with
a decreased concentration of MNase. The DNA was recovered by
phenol-chloroform extraction after treatment with proteinase K and
detected by Southern analysis with 32P-labeled 4xUAS.TRA reporter.
The positions of DNA fragments corresponding to mono-, di-, and
trinucleosome are indicated. (D) Expression of the GAL4-TR fusion
protein repressed transcription in the absence of T3 and activated
transcription in the presence of T3 from the 4xUAS.TRA reporter.
The control (ctrl) represents the primer extension product from the
endogenous storage histone H4 mRNA. Also shown is the expression
of GAL4-TR by Western blotting analysis with a GAL4 DBD-specific
antibody (sc-510; Santa Cruz Biotechnology). (E) ChIP assays revealed
the involvement of H3-K9 methylation in transcriptional regulation by
TR. The levels of H3-K9 methylation (boxed values below the gels)
were determined by ChIP assays with a K9-methylated-H3-specific
antibody. The acetylation of H3 was assayed with an antibody specific
for acetylated H3 (06-599; Upstate Biotechnology). The control ()
ChIP assay was performed with addition of protein A-Sepharose but
without specific antibody. As illustrated in panel B, the PCR A reac-
tion allows analysis of the promoter vicinity, whereas PCR B allows
analysis of a region approximately 2 kb downstream of the transcrip-
tional start site. Note that changes in H3-K9 methylation and acetyla-
tion were significant in the PCR A region but not in the PCR B region.
The data were quantified with a phosphoimager, and the results were
based on at least two independent experiments.
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with anti-acetylated H3 antibody revealed a decrease in acet-
ylation during repression by unliganded TR (PCR A, compare
lane 11 with 10). Although not obvious in this experiment, a
slight increase in acetylation of H3 was usually observed during
activation in the promoter region. Collectively, these results
showed that K9 methylation increased in the state of repres-
sion by unliganded TR and decreased in the state of activation
by liganded TR.
Involvement of other histone modifications in transcrip-
tional regulation by TR. We next used ChIP assays to assess
the possible involvement of other histone modifications in both
repression by unliganded TR and activation by liganded TR. A
representative result is shown in Fig. 2. Consistent with the
earlier result that K4 in H3 is a major site of histone methyl-
ation in ciliates, yeast cells, and human HeLa cells (45), H3-K4
methylation was readily detected in the control by ChIP assays
with a methylated H3-K4-specific antibody (mH3-K4). Inter-
estingly, in comparison to the control, the level of H3-K4
methylation decreased to about 50% in the presence of unli-
ganded TR and further decreased to about 30% in the pres-
ence of liganded TR. In multiple experiments, we have not
observed any significant change in methylation of H4-R3 under
either repression or activation conditions. However, a robust
increase (4.7-fold) in methylation of H3-R17 was observed
during transcriptional activation by liganded TR. In addition, a
decrease in methylation of H3-R17 during repression by unli-
ganded TR was also observed. The increase in H3-R17 meth-
ylation during activation by liganded TR is consistent with the
earlier finding that CARM1, the HMT that methylates H3-
R17, is a coactivator for nuclear hormone receptors (3, 7). We
suggest that the increase in methylation of H3-R17 is a result
of specific targeting of a Xenopus CARM1-like protein by
liganded TR.
Finally, as phosphorylation of H3-S10 has been linked di-
rectly to acetylation of H3-K14 and the transcriptional activa-
tion process, we also examined the levels of this dual modifi-
cation (pS10/acK14) under both repression and activation
conditions. Although the signals in ChIP assays were weak, this
dual modification showed a clear increase during activation
(4.3-fold) and decrease in repression (0.3-fold). This result
reveals a direct correlation of the dual modification in S10 and
K14 with transcription activation and is consistent with the
proposed role of phosphorylation of S10 in stimulation of
acetylation and subsequent transcriptional activation (11, 28).
Similar to H3-K9 methylation, all these observed changes in
histone modifications appear to be targeted to the promoter
vicinity, as in each case no significant change was detected in
the distal region (PCR B). Collectively, our results reveal that,
in addition to acetylation and deacetylation, histone methyl-
ation and phosphorylation are also involved in transcriptional
regulation by TR. Furthermore, our results indicate that dis-
tinct but complex patterns of histone modifications are associ-
ated with repression by unliganded TR and activation by ligan-
ded TR.
Functional interplay between histone acetylation and other
modifications. The above results revealed the involvement of
multiple histone modifications in transcriptional regulation by
TR. One possibility is that each of the observed modifications
reflects the recruitment of a specific enzyme (such as HMTs)
by either unliganded or liganded TR. Alternatively, it is also
possible that some of the modifications may be dependent on
or the consequence of other histone modifications. For in-
stance, it has been shown that methylation of H3-K9 interferes
with phosphorylation of S10 and that methylation of H3-K4
facilitates subsequent histone acetylation by p300 (36, 39, 52).
Since repression by unliganded TR is associated with histone
deacetylation as a result of specific targeting of the HDAC3-
containing SMRT/N-CoR complexes (24) and activation by
liganded TR is associated with recruitment of histone acetyl-
transferases such as CBP/p300 (9, 42), we next sought to de-
termine the effect of histone acetylation on other histone mod-
ifications. To do so, we took advantage of our previous
observation that treatment with trichostatin A (TSA), an
HDAC-specific inhibitor, can induce transcription activation
and histone hyperacetylation from repressive chromatin (24).
As illustrated in Fig. 3A, groups of oocytes were injected with
single-stranded DNA of the 4xUAS.pTRA reporter to assem-
ble DNA into repressive chromatin, treated or not with TSA
(0.3 M) overnight, and then assayed for transcription by
primer extension and histone modifications by ChIP assays.
The results in Fig. 3B showed that TSA treatment enhanced
transcription from the injected reporter. In agreement with its
ability to inhibit HDAC activity, TSA treatment increased the
levels of acetylation of both H3 and H4 (Fig. 3C). Note that the
effect of TSA on chromatin acetylation was global, being de-
tected in both the promoter vicinity (PCR A) and the distal
region (PCR B) in the pTRA reporter and all other regions
that we analyzed (data not shown).
In contrast to the increase in histone acetylation, there was
a concomitant decrease in the level of H3-K9 methylation after
TSA treatment in all regions tested (Fig. 3C). Assuming that
TSA has no direct inhibitory effect on the HMT(s) that methy-
lates H3-K9 (see below), this result indicates that the level of
histone acetylation has a significant influence on the level of
K9 methylation. Thus, not only can H3-K9 methylation inter-
fere with S10 phosphorylation and subsequent acetylation (39);
our result indicates that histone acetylation can also antago-
nize H3-K9 methylation.
We next extended our study to examine the effect of TSA
FIG. 2. Involvement of multiple histone modifications in transcrip-
tional regulation by TR. The experiments were performed as in Fig. 1
except ChIP assays were carried out with specific antibodies as indi-
cated. A fivefold longer exposure is shown for S10/acK14. Note that
changes in methylation of H3-K4, H3-R17, and dual modification
S10/acK14 were significant in the PCR A region but not in the PCR B
region.
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treatment on the dual modification pS10/acK14 and methyl-
ation of H3-K4, H4-R3, and H3-R17. As shown in Fig. 3D,
TSA treatment led to an increase (3.1-fold) in the dual mod-
ification pS10/acK14. This result is consistent with the corre-
lation of this modification with transcription activation. Inter-
estingly, TSA treatment also induced a strong increase in
H3-K4 methylation (5.2-fold). Thus, although no increase in
H3-K4 methylation was observed during activation by TR,
H3-K4 methylation was induced by histone hyperacetylation.
On the other hand, TSA treatment did not result in any sig-
nificant change in methylation of H4-R3 and H3-R17, suggest-
ing that the methylation of these sites is not directly influenced
by levels of histone acetylation. In summary, our results show
that histone hyperacetylation antagonizes H3-K9 methylation
and facilitates H3-K4 methylation and S10 phosphorylation,
thus revealing extensive interplay between histone acetylation
and other modifications.
TSA does not appear to inhibit H3-K9 methylation directly.
One possible conclusion from the above results is that TSA
directly inhibits (H3-K9) or promotes (H3-K4) HMT activity,
providing an alternative explanation for the observed decrease
in H3-K9 methylation and increase in H3-K4 methylation after
TSA treatment. To test this possibility, we examined whether
TSA could inhibit histone methylation in vitro by using Xeno-
pus oocyte extracts. We first demonstrated that Xenopus oocyte
extract contains HMT activities that can methylate both core
histone H3 and H4 (Fig. 4A). To look specifically at the effect
on H3-K9 methylation, we then repeated the experiment in
Fig. 4A but replaced the [3H]SAM with unlabeled SAM in
methylation reactions. Methylated histones were then fraction-
ated by SDS–15% PAGE, transferred to nitrocellulose, and
examined for H3-K9 methylation by Western blotting with the
anti-mH3-K9 antibody.
The results indicated that addition of TSA (1 M) had no
effect on H3-K9 methylation (Fig. 4B). Indeed, we did not
observe any inhibition of H3-K9 methylation in this in vitro
assay with concentrations of TSA ranging from 0.5 to 20 M
that were sufficient to inhibit HDAC activity. We thus conclude
that TSA has no direct effect on H3-K9 methylation and the
effect of TSA on H3-K9 methylation in Xenopus oocytes is not
due to direct inhibition of H3-K9 HMT activity by TSA.
Corepressor complexes such as Sin3, Mi-2/NURD, SMRT,
and N-CoR contain no detectable HMT activity. Strong evi-
dence indicates that repression by unliganded TR requires
histone deacetylation and is mediated through specific recruit-
ment of two closely related corepressors, SMRT and N-CoR
(10, 16, 20, 24). Both SMRT and N-CoR comprise a category
of class I HDAC-containing complexes by association with
HDAC3 (14, 25). Two other class I HDAC-containing com-
plexes, the HDAC1/2-containing Sin3 and Mi-2/NURD com-
plexes, also contribute to repression by unliganded TR (15, 34,
61), most likely through their effect on global deacetylation of
chromatin (24). The result that H3-K9 methylation increases
significantly during repression by unliganded TR raises the
intriguing possibility that some of the HDAC-containing com-
plexes involved in TR repression may contain H3-K9 HMT
activity.
FIG. 3. TSA treatment reveals extensive interplay between histone
acetylation, methylation, and phosphorylation. (A) Diagram illustrat-
ing the experimental scheme. Note that TSA treatment was performed
2 h after DNA injection to allow complete assembly of injected DNA
into chromatin. (B) TSA treatment resulted in transcription activation.
The expected primer extension product from the TRA promoter is
marked with an asterisk. The control (ctrl) was the primer extension
product from endogenous storage histone H4 mRNA. (C) ChIP assays
reveal the relationship of anticorrelation between histone acetylation
and H3-K9 methylation. The levels of H3-K9 methylation and acety-
lation of H3 and H4 were analyzed on both the promoter vicinity (PCR
A) and the distal region (PCR B). (D) TSA treatment resulted in a
drastic increase in H3-K4 methylation and in dual modification of S10
phosphorylation and K14 acetylation. A fourfold-longer exposure is
also shown for pS10/acK14. Note that TSA treatment did not result in
any significant change in H3-R17 and H4-R3 methylation.
FIG. 4. TSA does not appear to directly affect histone methylation.
(A) HMT activity in Xenopus oocytes was detected by an in vitro
methylation assay with core histones as the substrate and [3H]SAM as
the donor. The methylation of core histones was revealed by fluoro-
gram after separation on an SDS–15% PAGE gel. (B) Ability of TSA
to inhibit specifically the HMT activity toward H3-K9 in Xenopus
oocyte extracts. The experiments were performed essentially as for
panel A except unlabeled SAM was used. After separation by SDS–
15% PAGE, proteins were transferred to a nitrocellulose membrane,
and H3-K9 methylation was detected by Western analysis with the
methylated H3-K9-specific antibody (mK9-H3).
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To test this idea, we immunoprecipitated each complex from
HeLa nuclear extracts and tested HMT activity in vitro. As a
positive control, HeLa nuclear extract methylated both core
histones H3 and H4 in vitro in the presence of [3H]SAM under
our assay conditions (see Materials and Methods). However,
extensive effort failed to detect significant HMT activity in all
four immunoprecipitated corepressor complexes (Fig. 5A, up-
per panel). On the other hand, all the immunoprecipitated
complexes exhibited HDAC activity toward core histones la-
beled in vitro (Fig. 5B). Furthermore, highly purified Sin3 and
Mi-2/NURD complexes also contain no HMT activity (Yi
Zhang, personal communication). The absence of HMT activ-
ity in all four HDAC-containing corepressor complexes is also
consistent with a recent report on the purification of HMTs
from HeLa nuclear extracts (36). In this report, both H3-K9-
specific HMTs (SUV39H1-like and G9a-like activity) were
found to migrate as smaller complexes in comparison to the
known gel filtration profiles of corepressors SMRT, N-CoR,
Sin3A, and NURD complexes.
SUV39H1 interacts with TR and facilitates repression by
unliganded TR. Our ChIP assay results reveal that repression
by unliganded TR is associated not only with histone deacety-
lation but also with increased H3-K9 methylation. Given the
result that corepressor complexes did not appear to contain
HMT activity, we next tested whether TR could interact with
SUV39H1, the HMT that preferentially methylates H3-K9
(39). With an in vitro pulldown assay, we found that in vitro-
translated SUV39H1 bound to glutathione S-transferase
(GST)–TR (Fig. 6A). Although the interaction between
GST-TR and SUV39H1 was not influenced by the presence of
T3, the interaction was dependent on the presence of TR,
because no interaction was detected with control GST alone
(Fig. 6A).
The above result prompted us to test whether expression of
SUV39H1 could facilitate repression by unliganded TR. For
convenience in the repression assay, we assembled the
4xUAS.pTRA reporter into chromatin by injecting DNA in
the double-stranded form (which gives a relatively high basal
level of transcription in comparison to chromatin assembled
through injection of single-stranded DNA [59]). To observe
the effect of SUV39H1 on TR repression, we also chose to
inject a relatively low concentration of GAL4-TR mRNA (10
ng/l), which by itself led to a moderate repression (Fig. 6C,
compare lane 2 with 1). Importantly, expression of a Flag-
tagged SUV39H1 (F-SUV39H1) with GAL4-TR enhanced re-
pression in a dose-dependent manner (Fig. 6C and D, compare
lanes 3 and 4 with 2), whereas the expression of F-SUV39H1
alone had no effect on transcription (Fig. 6C, lane 5). Further-
more, the expression of SUV39H1 had no effect on the acti-
FIG. 5. Corepressor complexes implicated in TR repression con-
tain no detectable HMT activity. (A) The corepressor complexes Sin3,
SMRT, N-CoR, and Mi-2/NURD were individually immunoprecipi-
tated from HeLa nuclear extracts with complex-specific antibodies as
indicated and tested for HMT activity with core histones as substrates.
Note that no detectable HMT activity was found in each immunopre-
cipitated complex, although HeLa nuclear extract (lane 1) contained
abundant HMT activity toward H3 and less for H4. Also shown is
Coomassie staining of core histones. In contrast, all immunoprecipi-
tated corepressor complexes exhibited HDAC activity, as revealed by
an in vitro deacetylation assay (B). Lane 1, immunoprecipitation with
rabbit immunoglobulin G as a control for the deacetylation assay.
FIG. 6. SUV39H1 interacts with TR and facilitates TR repression
in an HMT activity-dependent manner. (A) Binding of SUV39H1 to
GST-TR as shown by an in vitro pulldown assay. In vitro-translated,
[35S]methionine-labeled SUV39H1 was tested for binding to GST or a
GST-TR fusion protein. The binding of SUV39H1 to GST-TR was
specific because no binding to GST was detected under the same
conditions. Note that the binding of SUV39H1 to GST-TR was not
affected by the presence of 1 M T3. (B) Diagrams showing the
structure of the wild-type and mutant SUV39H1s containing a Flag tag
at the N terminus. The mutant carries a mutation of histidine 324 to
lysine. (C) Expression of wild-type SUV39H1 in Xenopus oocytes fa-
cilitates repression by unliganded TR. Xenopus oocytes were injected
with mRNA encoding GAL4-TR (10 ng/l) alone or together with
mRNA encoding wild-type SUV39H1 (50 ng/l for lane 3 and 150
ng/l for lanes 4 and 5) and double-stranded DNA from the
4xUSA.TRA reporter. After overnight incubation, total RNA was
recovered from the injected oocytes, and the level of transcription was
determined by primer extension. Also shown in the bottom panel is the
expression of Flag-SUV39H1 in each group of injected Xenopus oo-
cytes as detected by Western analysis with a Flag-specific antibody.
The asterisk indicates a nonspecific band detected in Western analysis
which served as a loading control. (D) HMT activity is required for
SUV39H1 to promote TR repression. The experiment was carried out
as for panel C except mutant SUV39H1 was also included. Note that
the mutant SUV39H1 completely lost the ability to enhance repression
by unliganded TR (compare lanes 5 and 6 with 2 to 4).
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vation by GAL4-TR in the presence of T3 (data not shown).
The expression of F-SUV39H1 in oocytes was confirmed by
Western analysis with a Flag tag-specific antibody (Fig. 6C,
lower panel).
HMT activity is required for SUV39H1 to enhance TR re-
pression. With the observation that expression of SUV39H1
was able to enhance repression by unliganded TR, we next
wished to determine whether this enhancement required the
HMT activity of SUV39H1. To this end, we constructed a
mutant SUV39H1 with histidine 324 (H) changed to lysine (K)
(Fig. 6B). This mutation has been shown to completely inac-
tivate the SUV39H1 HMT activity (39). When tested together
with the wild-type SUV39H1, this mutant clearly lost its ability
to enhance TR repression (Fig. 6D). Furthermore, expression
of this mutant partially impaired the repression by unliganded
TR in several independent experiments (Fig. 6D, compare
lanes 5 and 6 with 2). Western analysis with a Flag-specific
antibody confirmed that the functional difference between
wild-type and mutant SUV39H1s was not due to their differ-
ential expression in Xenopus oocytes. Collectively, these results
demonstrate that SUV39H1 facilitates repression by unligan-
ded TR in an HMT activity-dependent manner.
DISCUSSION
In this study, we demonstrated that, in addition to histone
acetylation and deacetylation, other histone modifications, in-
cluding methylation and phosphorylation, are also involved in
transcriptional control by TR.
Involvement of H3-K9 methylation in repression by unligan-
ded TR. In addition to the expected histone deacetylation, we
demonstrated that repression by unliganded TR is accompa-
nied by an increase in H3-K9 methylation (Fig. 1), a decrease
in methylation of H3-K4 and H3-R17 and an decrease in phos-
phorylation of S10 (Fig. 2). While histone acetylation has been
well documented in transcriptional regulation, recent studies
have provided evidence for a diverse role of histone methyl-
ation in gene expression (8, 39, 53). Both lysine and arginine
residues in the N-terminal tails of core histones can be meth-
ylated, and the effect of methylation on transcription appears
to be site specific.
The identification of SUV39H1 and its yeast homologue
Clr4 as the H3-K9-specific HMT provides the first direct con-
nection between H3-K9 methylation and heterochromatin
gene silencing. The role of SUV39H1 and H3-K9 methylation
appears not to be restricted to heterochromatin gene silencing,
as recent studies showed that the retinoblastoma protein in-
teracts with SUV39H1 and targets it to the cyclin E promoter
for H3-K9 methylation and transcription repression (35, 49).
Our finding that H3-K9 methylation increases significantly dur-
ing repression by unliganded TR is consistent with a role of
H3-K9 methylation in transcription repression. In support of
this, we demonstrated that SUV39H1 interacts with TR in
vitro and facilitates TR repression in an HMT activity-depen-
dent manner (Fig. 6). These results indicate that H3-K9 meth-
ylation is unlikely to be a simple consequence of TR repression
but contributes to repression by unliganded TR.
As H3-K9 methylation has been shown to create a binding
site for HP1 in the N-terminal tail of H3 (2, 22), one mecha-
nism by which H3-K9 methylation facilitates TR repression is
to recruit HP1. Future work will test whether HP1 is indeed
recruited to the promoter region during repression by unligan-
ded TR. Alternatively, H3-K9 methylation could enhance re-
pression through its antagonistic effect on S10 phosphorylation
and histone acetylation, both correlating with transcriptional
activation by liganded TR. Consistent with this idea, we found
that S10 phosphorylation decreases during repression by unli-
ganded TR and increases during activation by liganded TR.
Given the conservation in the mechanisms of transcriptional
regulation by the NR superfamily, our results suggest that the
H3-K9 methylation is likely to extend far beyond heterochro-
matic gene silencing and be widely used for transcriptional
repression by NRs and other transcription factors as well. In
this regard, it is noteworthy that H3-K9 methylation appears
nearly unchanged in bulk H3 prepared from primary mouse
embryonic fibroblasts derived from Suv39 h1 and Suv39 h2
double-knockout mice, suggesting that H3-K9 methylation is
widely present in euchromatin (39).
Correlation of H3-K4 methylation with transcription. In
contrast to the increase in H3-K9 methylation, we also ob-
served a decrease in H3-K4 methylation during repression by
unliganded TR. Recent studies with ChIP assays on fission
yeast and the chicken -globin locus indicate that H3-K9 meth-
ylation is restricted to the heterochromatic regions, whereas
H3-K4 methylation is specific to the surrounding euchromatic
regions (27, 37). In addition, immunofluorescence studies in-
dicate that H3-K4 methylation is largely absent from the inac-
tive X chromosome, which is enriched in H3-K9 methylation
(5). Moreover, it has been shown recently that methylation of
H3-K4 by Set9, also called Set7, antagonizes H3-K9 methyl-
ation and precludes the association of the NURD complex
with the H3 tail (36, 52). Set9 enhanced transcriptional acti-
vation by GAL4-VP16, and, importantly, a mutation in Set9
that abolished its enzymatic activity also impaired the ability of
Set9 to stimulate activation by GAL4-VP16 (36). Collectively,
these results define H3-K4 methylation as a marker for eu-
chromatin and suggest a role for H3-K4 methylation in tran-
scription activation (45).
While the decrease in H3-K4 methylation during repression
by unliganded TR is consistent with such an idea, it was sur-
prising to find that H3-K4 methylation decreased further dur-
ing activation by liganded TR (Fig. 2). Our results on H3-K4
methylation indicate a lack of direct correlation of this modi-
fication with transcription. Indeed, work with S. cerevisiae in-
dicates that H3-K4 methylation may be involved in transcrip-
tion repression as well. In S. cerevisiae, Set1 is likely to be the
major if not the only enzyme responsible for H3-K4 methyl-
ation (6). Genetic experiments indicate that Set1 is required
for rDNA silencing and silencing at telomeres and mating type
loci (6). It is unknown currently how the same modification can
be involved in such apparently opposite transcriptional events.
However, according to the histone code hypothesis (19, 43), it
is likely that the overall pattern of histone modifications, not a
single modification, determines the outcome on chromatin
structure and function. Thus, a single modification can have
distinct effects on transcription depending on the combination
with other histone modifications.
Involvement of methylation at H3-R17 and H4-R3 in tran-
scriptional activation by liganded TR. In addition to H3-K9
and K4 methylation, the level of H3-R17 methylation showed
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a reduction during repression by unliganded TR and an in-
crease during activation by liganded TR (Fig. 2). The NR
coactivator CARM1 has been shown to methylate R3, R17,
and R26 in H3 (41) and facilitate NR activation in concert with
SRC/p160 family coactivators (7, 8, 21). More recently, activa-
tion of the estrogen receptor-regulated pS2 gene was shown to
be associated with a dramatic increase in H3-R17 methylation,
which correlated with specific recruitment of CARM1 (3).
Thus, the increased H3-R17 methylation that we observed is
likely a result of specific recruitment of a Xenopus CARM1-
like activity by liganded TR. Interestingly, although the H4-R3
methylation is largely carried out in mammalian cells by
PRMT1, which is also a coactivator for NRs (53), we have not
observed any change in H4-R3 methylation during repression
by unliganded TR and activation by liganded TR. Whether this
result reflects the absence of a PRMT1-like activity in Xenopus
oocytes remains to be determined.
Correlation of S10 phosphorylation with activation by ligan-
ded TR. In addition to methylation on various sites described
above, the dual modification pS10/acK14 in H3 displays a de-
crease during repression and drastic increase during activation.
While we have yet to examine S10 phosphorylation indepen-
dent of K14 acetylation, the fact that no significant change in
acetylation of H3 and H4 was observed during activation by
liganded TR in comparison to the controls (Fig. 1) implies an
increase in S10 phosphorylation during activation. In S. cerevi-
siae, S10 phosphorylation is coupled to K14 acetylation and is
required for transcriptional activation by a subset of Gcn5-
regulated genes (28). In vitro, S10 phosphorylation has been
shown to promote subsequent histone acetylation by several
histone acetyltransferases (11, 28). Thus, an increase in S10
phosphorylation during activation by liganded TR is consistent
with a role of S10 phosphorylation in promoting transcription
activation. So far, several S10-specific kinases have been iden-
tified, including the Ip11/Aurora family kinases and the kinase
Snf1 (17, 29). It is unknown currently whether the enhanced
S10 phosphorylation is a result of the direct or indirect recruit-
ment of an S10-specific kinase by liganded TR.
Interplay between histone acetylation and other modifica-
tions. By using the HDAC inhibitor TSA, we showed that TSA
treatment not only induced histone hyperacetylation but also
resulted in a reduction in H3-K9 methylation, increase in
H3-K4 methylation and S10 phosphorylation, and no change in
methylation of H3-R17 and H4-R3. As TSA had no effect on
H3-K9 methylation, at least in vitro (Fig. 4), the reduction in
H3-K9 methylation was unlikely a direct inhibition by TSA
of H3-K9 methylation. Instead, this result most likely reflects a
functional interplay between histone acetylation and H3-K9
methylation. Such an antagonistic outcome between H3-K9
methylation and acetylation is not surprising, given the exclu-
sive nature of H3-K9 methylation and acetylation. Neverthe-
less, such an inverse correlation between H3-K9 methylation
and acetylation further enforces the idea that H3-K9 methyl-
ation is directly correlated with transcription repression.
In addition, TSA treatment also led to a strong increase in
H3-K4 methylation (Fig. 3). As with H3-K9 methylation, our
preliminary results indicate that TSA has no effect on H3-K4
methylation in a Xenopus oocyte extract in vitro. We suggest
that the effect of TSA on H3-K4 again is a direct or indirect
result of histone hyperacetylation. As TSA treatment induced
a strong increase in H3-K4 methylation, our result suggests
that histone hyperacetylation is likely to facilitate subsequent
methylation on H3-K4. Nevertheless, as the level of H3-K4
methylation was actually found to decrease during activation
by liganded TR (Fig. 2), H3-K4 methylation is unlikely to be
essential for the transcriptional activation process. As dis-
cussed above, the effect of H3-K4 methylation on transcription
may well depend on its combination with other histone mod-
ifications.
Furthermore, TSA treatment also led to a strong increase in
dual modification of S10 phosphorylation and K14 acetylation.
Although S10 phosphorylation has been shown to facilitate
subsequent histone acetylation both in vitro and in vivo, his-
tone acetylation on K14 appears to have no effect on S10
phosphorylation (11, 28). How TSA treatment promotes S10
phosphorylation is thus not clear. One possibility is that, al-
though acetylation at K14 alone has no effect on S10 phos-
phorylation, acetylation on multiple sites in H3 or other his-
tones and/or methylation at H3-K4 may facilitate S10
phosphorylation. Alternatively, the increased S10 phosphory-
lation may not be a result linked directly to histone acetylation
per se but a consequence of transcription activation. Taken
together, our results provide strong evidence for extensive
functional interplay between histone acetylation, methylation,
and phosphorylation.
SUV39H1 facilitates TR repression in an HMT-dependent
manner. As repression by unliganded TR is believed to be
mediated through corepressor complexes, the strong increase
in H3-K9 methylation during repression by unliganded TR
suggests that one or more of the HDAC-containing corepres-
sor complexes involved in TR repression may potentially con-
tain HMT activity responsible for H3-K9 methylation. It is thus
rather disappointing that our extensive efforts failed to reveal
HMT activity in several well-characterized corepressor com-
plexes, including HDAC3-containing SMRT and N-CoR com-
plexes and HDAC1/2-containing Sin3 and Mi-2/NURD com-
plexes (14, 25, 51, 61–63). Despite ample HMT activities in
HeLa nuclear extracts, neither immunoprecipitated corepres-
sor complexes SMRT, N-CoR, Sin3, and Mi-2/NURD nor
their highly purified fractions contained detectable HMT ac-
tivity (Fig. 5). Instead, an interaction between TR and
SUV39H1 was observed in an in vitro GST pulldown assay.
Although this interaction was independent of hormone in our
in vitro interaction assay and remains to be confirmed in vivo,
the interaction is likely of functional significance, as expression
of SUV39H1 in Xenopus oocytes facilitated repression by un-
liganded TR (Fig. 6). Importantly, the ability of SUV39H1 to
enhance TR repression is directly correlated with its HMT
activity, since an SUV39H1 mutant (H324K) defective in HMT
activity was also impaired in enhancing repression by unligan-
ded TR (Fig. 6).
While our results demonstrate a role of H3-K9 methylation
in repression by unliganded TR, it is unknown whether recruit-
ment of a Xenopus homolog of SUV39H1 is responsible for
increased H3-K9 methylation during repression by unliganded
TR. Given the strong antagonism between histone acetylation
and H3-K9 methylation as revealed by TSA treatment, it is also
possible that the increased H3-K9 methylation may not be
entirely due to the specific recruitment of an HMT by unligan-
ded TR. Instead, histone hypoacetylation as a result of specific
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recruitment of SMRT and N-CoR complexes could presum-
ably generate a better substrate for H3-K9 methylation and
thus lead to an increased methylation in K9.
Is histone methylation reversible? As discussed above, we
observed significant alterations in histone methylation after
TSA treatment and during repression or activation by unligan-
ded and liganded TR, respectively. Our results thus raise an
intriguing question: whether histone methylation is reversible.
On the basis of thermodynamic principles, methyl-lysine and
methyl-arginine are believed to be stable. However, demeth-
ylation could theoretically be catalyzed by histone demethy-
lases, although the existence of histone demethylases has yet to
be demonstrated. The results that H3-K9 methylation in-
creases during repression by unliganded TR and decreases
during activation by liganded TR or after treatment with TSA
suggest that site-specific histone methylation is reversible. The
decrease in H3-K9 methylation is unlikely to be due to the
effect of liganded TR or TSA on chromatin assembly, as chro-
matin assembly via the replication-coupled pathway is a fast
event (about 30 min after injection) and was complete before
addition of hormone or TSA (2 h after injection).
If histone demethylases do not exist, an alternative approach
through proteolytic processing has been proposed for removal
of methylated histone tails (19). However, if histone methyl-
ation is widely involved in regulation of gene expression, as
shown here and proposed in the histone code hypothesis (19,
43), it will likely be reversible in order to meet the acute
response in control of gene expression.
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